Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 93495 · Class II · HCSC-Blood Center
Key facts
| Event ID | 93495 |
|---|---|
| Recall numbers | B-0066-2024 |
| Recalling firm | HCSC-Blood Center |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell product, identified as unsuitable due to a collection deviation, was distributed. |
| Initiation date | Aug 11, 2023 |
| Report date | Dec 13, 2023 |
| Termination date | Dec 5, 2023 |
| City | Bethlehem |
| State | PA |
| Country | United States |
| FEI number | 2573135 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: